Literature DB >> 21740148

Sympathomimetic toxicity in a case of analytically confirmed recreational use of naphyrone (naphthylpyrovalerone).

Adrian Derungs1, Simeon Schietzel, Markus R Meyer, Hans H Maurer, Stephan Krähenbühl, Matthias E Liechti.   

Abstract

CONTEXT: Naphyrone (naphthylpyrovalerone) is a cathinone derivative and recreational drug related to mephedrone. CASE: We report a 31-year-old man who ingested a dose of naphyrone (100 mg), which produced acute sympathomimetic toxicity with restlessness, insomnia, anxiety, and hallucinations lasting for 2 days. Naphyrone was detected in the patient's plasma by gas chromatography with mass spectrometry at concentrations of 0.03 and 0.02 mg/L, 40 and 60 h after drug intake, respectively. DISCUSSION: Based on the present case report and user web-reports, as well as on the chemical structure and pharmacological characteristics, naphyrone produces stimulant-like psychotropic effects and sympathomimetic toxicity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21740148     DOI: 10.3109/15563650.2011.592838

Source DB:  PubMed          Journal:  Clin Toxicol (Phila)        ISSN: 1556-3650            Impact factor:   4.467


  9 in total

1.  Validation of the only commercially available immunoassay for synthetic cathinones in urine: Randox Drugs of Abuse V Biochip Array Technology.

Authors:  Kayla N Ellefsen; Sébastien Anizan; Marisol S Castaneto; Nathalie A Desrosiers; Thomas M Martin; Kevin L Klette; Marilyn A Huestis
Journal:  Drug Test Anal       Date:  2014-03-21       Impact factor: 3.345

2.  Substituted methcathinones differ in transporter and receptor interactions.

Authors:  Amy J Eshleman; Katherine M Wolfrum; Meagan G Hatfield; Robert A Johnson; Kevin V Murphy; Aaron Janowsky
Journal:  Biochem Pharmacol       Date:  2013-04-10       Impact factor: 5.858

3.  Analysis of neurotransmitter levels in addiction-related brain regions during synthetic cathinone self-administration in male Sprague-Dawley rats.

Authors:  Julie A Marusich; Elaine A Gay; Bruce E Blough
Journal:  Psychopharmacology (Berl)       Date:  2018-09-06       Impact factor: 4.530

4.  Clinical and toxicological findings of acute intoxication with synthetic cannabinoids and cathinones.

Authors:  Yuji Fujita; Atsuhiko Koeda; Yasuhisa Fujino; Makoto Onodera; Satoshi Kikuchi; Hisae Niitsu; Yasumasa Iwasaki; Kiyotaka Usui; Yoshihiro Inoue
Journal:  Acute Med Surg       Date:  2015-12-28

Review 5.  The Bridge Between Classical and "Synthetic"/Chemical Psychoses: Towards a Clinical, Psychopathological, and Therapeutic Perspective.

Authors:  Laura Orsolini; Stefania Chiappini; Duccio Papanti; Domenico De Berardis; John M Corkery; Fabrizio Schifano
Journal:  Front Psychiatry       Date:  2019-11-20       Impact factor: 4.157

6.  Pharmacological characterization of designer cathinones in vitro.

Authors:  L D Simmler; T A Buser; M Donzelli; Y Schramm; L-H Dieu; J Huwyler; S Chaboz; M C Hoener; M E Liechti
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

Review 7.  DARK Classics in Chemical Neuroscience: Cathinone-Derived Psychostimulants.

Authors:  Steven J Simmons; Jonna M Leyrer-Jackson; Chicora F Oliver; Callum Hicks; John W Muschamp; Scott M Rawls; M Foster Olive
Journal:  ACS Chem Neurosci       Date:  2018-05-11       Impact factor: 4.418

Review 8.  Emerging drugs of abuse: current perspectives on substituted cathinones.

Authors:  Magalie Paillet-Loilier; Alexandre Cesbron; Reynald Le Boisselier; Joanna Bourgine; Danièle Debruyne
Journal:  Subst Abuse Rehabil       Date:  2014-05-26

9.  Synthetic cathinone abuse.

Authors:  Michael Capriola
Journal:  Clin Pharmacol       Date:  2013-07-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.